Search
Now showing items 1-9 of 9
Escherichia coli pathotypes and Shigella sero-groups in diarrheic children in Nairobi city, Kenya
(Gastroenterology and Hepatology From Bed to Bench, 2017-06-29)
m:
In the present study, we investigated the prevalence of E. coli pathotypes and Shigella sero-groups and their antimicrobial profiles among diarrheic children in Nairobi city, Kenya.
Background:
Although diarrheagenic ...
Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users
(Endocrine Connections, 2015-12)
Adiponectin is an important marker of anthropometric profiles of adipose tissue. However, association of adiponectin and adiposity in HIV mono- and co-infected and hepatitis (HCV) injection drug users (IDUs) has not been ...
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users
(AIDS Research and Therapy, 2015-08-15)
Background
Although injection drug use drives antiretroviral drug resistance, the prevalence of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We, therefore, explored PI resistance mutations ...
Circulating Interferon-Gamma Levels Are Associated with Low Body Weight in Newly Diagnosed Kenyan Non-Substance Using Tuberculosis Individuals
(National Library of Medicine, 2016-01-05)
Although interferon-gamma, interleukin-10, and adiponectin are key immunopathogenesis mediators of tuberculosis, their association with clinical manifestations of early stage disease is inconclusive. We determined ...
Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users
(Endocrine Connections, 2015-12)
Adiponectin is an important marker of anthropometric profiles of adipose tissue. However, association of adiponectin and adiposity in HIV mono- and co-infected and hepatitis (HCV) injection drug users (IDUs) has not been ...
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users
(AIDS Research and Therapy, 2015-08-15)
Background
Although injection drug use drives antiretroviral drug resistance, the prevalence of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We, therefore, explored PI resistance mutations ...
Socio-demographic and sexual practices associated with HIV infection in Kenyan injection and non-injection drug users
(BMC Public Health, 2018-01-30)
Background
Substance use is increasingly becoming prevalent on the African continent, fueling the spread of HIV infection. Although socio-demographic factors influence substance consumption and risk of HIV infection, the ...
Clinical chemistry profiles in injection heroin users from Coastal Region, Kenya
(BMC Clin Pathol, 2014-07-09)
Background: Although the co-burden of injection drug use and HIV is increasing in Africa, little is known about the laboratory markers of injection drug use and anti-retroviral treatment (ART) in Kenyan injection drug ...
Erratum to: Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya
(BMC Infectious Diseases, 2015-09-03)
Erratum
After publication of [1] it came to the authors’ attention that Mark K. Webale’s name was displayed incorrectly. The correct spelling of their name has been updated in the original article and is included in this erratum.